Aortic valve neocuspidization in patients under 65 years old.

Yasunori IidaShigeharu SawaSusumu FujiiHideyuki Shimizu

Published in: General thoracic and cardiovascular surgery (2020)

AVNeo in patients aged under 65 years appears to be suitable considering its early and midterm outcomes. Verification and follow-up of its long-term outcomes and reliability are indispensable.

Keyphrases

aortic valve
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
transcatheter aortic valve replacement
adipose tissue
skeletal muscle
patient reported outcomes
insulin resistance